Selective σ ligands block stimulant effects of cocaine

European Journal of Pharmacology

Volumn 201, Issue 2-3, 1991, Pages 251-252

  Menkel, Melissa ^c   Terry, Philip ^c   Pontecorvo, Michael ^a,b   Katz, Jonathan L ^c   Witkin, Jeffrey M ^c  

^a NIDA Addiction Research Center   (United States)

^b Nova Pharmaceuticals   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; CLOZAPINE; COCAINE; HALOPERIDOL; PRECLAMOL; RIMCAZOLE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, OPIOID; RECEPTORS, SIGMA; STIMULATION, CHEMICAL;

EID: 0025910330     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(91)90355-T     Document Type: Article

References (5)

1. The pharmacology of cocaine related to its abuse
2. Novel antipsychotic drugs share high affinity for σ receptors
3. Cocaine binding at σ receptors
4. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies
5. Sigma receptors: Biology and function